Full Text View
Tabular View
No Study Results Posted
Related Studies
Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), January 2009
First Received: September 18, 2002   Last Updated: August 24, 2009   History of Changes
Sponsor: National Human Genome Research Institute (NHGRI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00046059
  Purpose

Attention Deficit Hyperactivity Disorder (ADHD) is the most common behavioral disorder in childhood, affecting 3-5% of children between the ages of 7 and 17. Family studies suggest that there is a genetic component to ADHD. Scientists believe that it is a complex disorder in which two or more genes may be involved.

Potentially eligible families will be asked to give written consent to participate and will be asked to complete questionnaires for each member in the family. In addition, an interview will be administered to the parent of minors enrolled in the study to determine their eligibility for being in the study. This screening tool is computerized and will take approximately 45 minutes to administer per child.

Once screenings are completed, a blood collection kit will be sent to the family to take to their local medical care provider, have blood samples drawn and sent to NIH. There is no cost to the family to participate. We would like to enroll entire families, with both parents and all children.


Condition
Attention Deficit Disorder With Hyperactivity

Study Type: Observational
Official Title: Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 4000
Study Start Date: February 2000
Estimated Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)
Detailed Description:

A study of the hypothesis that Attention Deficit Hyperactivity Disorder (ADHD) is a genetically influenced brain disorder has been undertaken using a two armed approach: 1) a large, extended pedigree study done in Columbia, South America in a population isolate called the Paisa; and 2) a U.S. based study with at least one affected child and at least one sibling (either affected or unaffected), and their parents. Following careful phenotyping, DNA from blood samples from these two groups will be analyzed through a genome-wide scan for linkage and positional candidate approach to search for genes associated with ADHD. The prefrontal cortex is known to play a very important role in the processing of emotions and impulsivity. Measurement of brain metabolites in this region may be very useful in phenotyping ADHD. Thus, in the Columbian population, in a subset of already recruited individuals, phenotyping will include proton magnetic resonance spectroscopy (H MRS) to detect biochemical phenotypes which may be correlated with genetic markers for ADHD.

  Eligibility

Ages Eligible for Study:   7 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

For both the U.S. and the Columbian Studies, we plan to obtain blood samples from subjects meeting the following criteria:

Children , ages 7-17, affected with ADHD with siblings who are either affected or unaffected, and their parents. (in the Columbian Study, we will also gather information and blood samples from extended families).

Adult participants 18 years or older selected for MRS from the Paisa population will be included if they:

  1. share the haplotype that is in linkage disequilibrium at chormosome 11 p
  2. do not have devices such as pace makers, cochlear implants, metal clips in the brain, etc that would preclude them from undergoing magnetic resonance technology
  3. are not pregnant (pregnancy test will be administered) or breastfeeding
  4. do not have a mental condition such as claustrophobia which would make magnetic resonance tehcnology unacceptable to them.

    EXCLUSION CRITERIA:

    Exclude the following (if the condition could cause false positive ADHD):

    • Prematurity
    • Neurological conditions
    • Cardiac surgery
    • Prenatal drug exposure
    • Hydrocephaly
    • Mental Retardation (IQ of less than 80)
    • Known genetic syndromes
    • Known CNS disorders
    • Known lead toxicity
    • Tourette Disorder
    • Obsessive-Compulsive Disorder
    • Major Depression on both proband and affected sibling
    • Pervasive Developmental Disorder
    • Age under 7 years old
    • Autism
    • Other Psychoses
    • Post Traumatic Stress Disorder
    • Language Disorder (if known)
    • Severe Sensory Impairment (visual and hearing).

    No bilineal families for statistical reasons are to be included, i.e. families in which both father and mother are known to be affected with ADHD. In order to involve either parent, there must be affected siblings.

    Include, but note:

    • Oppositional Defiant Disorder
    • Conduct Disorder
    • Tic Disorder
    • Obsessive/Compulsive Symptoms
    • Anxiety/Phobias
    • Learning Disabilities.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00046059

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, California
University of California, Irvine Medical Center Recruiting
Orange, California, United States, 92668
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Colombia
University of Antioquia Recruiting
Medillin, Colombia
Sponsors and Collaborators
  More Information

Additional Information:
Publications:
Study ID Numbers: 000058, 00-HG-0058
Study First Received: September 18, 2002
Last Updated: August 24, 2009
ClinicalTrials.gov Identifier: NCT00046059     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Linkage
Gene Identification
ADHD
Hyperactivity
Attention Deficit Hyperactivity Disorder
ADHD
Hyperactivity

Additional relevant MeSH terms:
Signs and Symptoms
Pathologic Processes
Disease
Attention Deficit Disorder with Hyperactivity
Mental Disorders
Nervous System Diseases
Mental Disorders Diagnosed in Childhood
Neurologic Manifestations
Attention Deficit and Disruptive Behavior Disorders
Hyperkinesis
Dyskinesias

ClinicalTrials.gov processed this record on November 22, 2009